Literature DB >> 29455562

Spatiotemporal Characteristics of the HIV-1 CRF02_AG/CRF63_02A1 Epidemic in Russia and Central Asia.

Evangelia-Georgia Kostaki1, Timokratis Karamitros2, Marina Bobkova3, Martha Oikonomopoulou1, Gkikas Magiorkinis1,2, Federico Garcia4, Angelos Hatzakis1, Dimitrios Paraskevis1.   

Abstract

Eastern European countries, including Russia, Ukraine, and other former Soviet Union (FSU) countries, have experienced a human immunodeficiency virus (HIV) epidemic spreading mostly among people who inject drugs (PWID). We aimed to investigate the origin and the dispersal patterns of HIV-1 CRF02_AG in Russia and other FSU countries. We studied 136 CRF02_AG sequences originating from Russia, and FSU countries along with a globally sampled dataset of 3,580 CRF02_AG sequences. Maximum-likelihood phylogeny reconstruction with bootstrap evaluation was conducted in RAxML. Bayesian phylogeographic analysis was performed in BEAST v1.8 using the discrete trait model. We found that all CRF02_AG sequences from Russia and other FSU countries formed a single monophyletic cluster within CRF02_AG radiation. The Russian/FSU clade was classified as CRF63_02A1. Sequences from the FSU countries clustered further within distinct subclades (two from Russia, three from Uzbekistan, and one Kazakhstan) according to the geographic origin of sampling. Molecular clock analysis revealed that the time to the most recent common ancestor (tMRCA) of the CRF63_02A1 epidemic was in 1996 [95% higher posterior density (95% HPD): 1992-1999], while for the two Russian subclades, tMRCA was estimated in 2003 (95% HPD: 2001-2004) and in 2007 (95% HPD: 2005-2008). Phylogeographic analysis suggested that the potential origin of the epidemic was in Uzbekistan. Early dispersal of CRF63_02A1 occurred in Kazakhstan and Uzbekistan and thereafter the epidemic spread to Russia. Notably, spillover transmissions to Russia kept occurring from both countries. Previous studies have shown that Russia and Ukraine have provided the source for the PWID-driven, HIV-1 subtype-A epidemic, spreading across the FSU countries (AFSU). In great contrast, CRF63_02A1 established an epidemic in central Asia (Uzbekistan and Kazakhstan), from where it subsequently disseminated to Russia. Our study suggests that cross-border transmissions among PWID occur bidirectionally between Russian and other FSU populations. These results are of public health importance and suggest that prevention actions have to be reinforced in this area to assist the management of high-risk practices.

Entities:  

Keywords:  CRF63_02A1; HIV; Russia; central Asia; epidemiology; phylogeography

Mesh:

Year:  2018        PMID: 29455562     DOI: 10.1089/AID.2017.0233

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Human Immunodeficiency Virus-1 Diversity in the Moscow Region, Russia: Phylodynamics of the Most Common Subtypes.

Authors:  Aleksey Lebedev; Natalya Lebedeva; Fedor Moskaleychik; Alexander Pronin; Elena Kazennova; Marina Bobkova
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

2.  Identifying HIV-1 Transmission Clusters in Uzbekistan through Analysis of Molecular Surveillance Data.

Authors:  Aleksey Lebedev; Anna Kuznetsova; Kristina Kim; Ekaterina Ozhmegova; Anastasiia Antonova; Elena Kazennova; Aleksandr Tumanov; Adkhamjon Mamatkulov; Evgeniya Kazakova; Nargiz Ibadullaeva; Krestina Brigida; Erkin Musabaev; Dildora Mustafaeva; Visola Rakhimova; Marina Bobkova
Journal:  Viruses       Date:  2022-07-29       Impact factor: 5.818

3.  Spatiotemporal dynamics of HIV-1 CRF63_02A6 sub-epidemic.

Authors:  Mariya V Sivay; Lada V Maksimenko; Irina P Osipova; Anastasiya A Nefedova; Mariya P Gashnikova; Dariya P Zyryanova; Vasiliy E Ekushov; Alexei V Totmenin; Tatyana M Nalimova; Vladimir V Ivlev; Dmitriy V Kapustin; Larisa L Pozdnyakova; Sergey E Skudarnov; Tatyana S Ostapova; Svetlana V Yaschenko; Olga I Nazarova; Aleksander S Chernov; Tatyana N Ismailova; Rinat A Maksutov; Natalya M Gashnikova
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

4.  SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies.

Authors:  Timokratis Karamitros; Gethsimani Papadopoulou; Maria Bousali; Anastasios Mexias; Sotirios Tsiodras; Andreas Mentis
Journal:  J Clin Virol       Date:  2020-08-11       Impact factor: 3.168

5.  Near Full-length Genomic Sequencing and Molecular Analysis of HIV-Infected Individuals in a Network-based Intervention (TRIP) in Athens, Greece: Evidence that Transmissions Occur More Frequently from those with High HIV-RNA.

Authors:  Evangelia-Georgia Kostaki; Daniel Frampton; Dimitrios Paraskevis; Katerina Pantavou; Bridget Ferns; Jade Raffle; Paul Grant; Zisis Kozlakidis; Andria Hadjikou; Eirini Pavlitina; Leslie D Williams; Angelos Hatzakis; Samuel R Friedman; Eleni Nastouli; Georgios K Nikolopoulos
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

6.  Prevalence and spatiotemporal dynamics of HIV-1 Circulating Recombinant Form 03_AB (CRF03_AB) in the Former Soviet Union countries.

Authors:  Aleksey Lebedev; Oksana Pasechnik; Ekaterina Ozhmegova; Anastasiia Antonova; Aleksey Blokh; Liliya Grezina; Tatiana Sandyreva; Natalia Dementeva; Elena Kazennova; Marina Bobkova
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

Review 7.  Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?

Authors:  Fatma Elrashdy; Elrashdy M Redwan; Vladimir N Uversky
Journal:  Biomolecules       Date:  2020-09-11

8.  Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.

Authors:  Alina Kirichenko; Dmitry Kireev; Alexey Lopatukhin; Anastasia Murzakova; Ilya Lapovok; Daria Saleeva; Natalya Ladnaya; Agigat Gadirova; Sabina Ibrahimova; Aygun Safarova; Trdat Grigoryan; Arshak Petrosyan; Tatevik Sarhatyan; Elena Gasich; Anastasia Bunas; Iryna Glinskaya; Pavel Yurovsky; Rustam Nurov; Alijon Soliev; Laylo Ismatova; Erkin Musabaev; Evgeniya Kazakova; Visola Rakhimova; Vadim Pokrovsky
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.